المؤلفون: Alexandre Sita, Gabriela E. Birlem, Paula R. de Almeida, Janaína F. Stein, Larissa Mallmann, Meriane Demoliner, Mariana S. da Silva, Juliana S. Gularte, Alana W. Hansen, Juliane D. Fleck, Fernando R. Spilki, Severino S. S. Higino, Sergio S. de Azevedo, Daniela T. da Rocha, Matheus N. Weber

المصدر: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]. 53(4)

مصطلحات موضوعية: Feces, Mastadenovirus, Guinea Pigs, Media Technology, Humans, Animals, Animals, Wild, Sequence Analysis, DNA, Microbiology, Phylogeny

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfb3b82a95b1e5c9398427d01d9fb4a1
https://pubmed.ncbi.nlm.nih.gov/36104574

المؤلفون: Harrington KJ; Royal Marsden Hospital/The Institute of Cancer Research National Institute for Health and Care Research Biomedical Research Centre, London, United Kingdom., Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Gillison M; The University of Texas MD Anderson Cancer Center, Houston., Tahara M; National Cancer Center Hospital East, Chiba, Japan., Argiris A; Hygeia Hospital, Marousi, Greece.; Thomas Jefferson University, Philadelphia, Pennsylvania., Fayette J; Centre Léon Bérard, Lyon, France.; Hôpital Saint-André, Bordeaux, France., Schenker M; Centrul de Oncologie Sf Nectarie, Craiova, Romania., Bratland Å; Oslo University Hospital, Oslo, Norway., Walker JWT; University of Alberta, Edmonton, Alberta, Canada., Grell P; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Even C; Gustave Roussy, Villejuif, France., Chung CH; Moffitt Cancer Center, Tampa, Florida., Redman R; University of Louisville, Brown Cancer Center, Louisville, Kentucky., Coutte A; Centre Hospitalier Universitaire d'Amiens, Amiens, France., Salas S; Assistance Publique-Hôpitaux de Marseille, Marseille, France., Grant C; St James's Hospital, Dublin, Ireland., de Azevedo S; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Soulières D; Université de Montréal, Montréal, Quebec, Canada., Hansen AR; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Wei L; Bristol Myers Squibb, Princeton, New Jersey., Khan TA; Bristol Myers Squibb, Princeton, New Jersey., Miller-Moslin K; Bristol Myers Squibb, Princeton, New Jersey., Roberts M; Bristol Myers Squibb, Princeton, New Jersey., Haddad R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

المصدر: JAMA oncology [JAMA Oncol] 2023 Jun 01; Vol. 9 (6), pp. 779-789.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Squamous Cell*/drug therapy , Head and Neck Neoplasms*/drug therapy, Male ; Humans ; Middle Aged ; Nivolumab/adverse effects ; Nivolumab/administration & dosage ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Double-Blind Method ; Platinum ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Ipilimumab/adverse effects ; Ipilimumab/administration & dosage ; Immunotherapy

المؤلفون: Shitara K; National Cancer Center Hospital East, Kashiwa, Japan., Ajani JA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moehler M; Johannes-Gutenberg University Clinic, Mainz, Germany., Garrido M; Clinica San Carlos de Apoquindo, Pontificia Universidad Católica, Santiago, Chile., Gallardo C; Fundación Arturo López Pérez, Providencia, Chile., Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China., Yamaguchi K; The Cancer Institute Hospital of JFCR, Tokyo, Japan., Wyrwicz L; Klinika Onkologii i Radioterapii, Narodowy Instytut Onkologii, Warszawa, Poland., Skoczylas T; II Klinika Chirurgii Ogólnej, Gastroenterologicznej i Nowotworów Układu Pokarmowego, Medical University of Lublin, Lublin, Poland., Bragagnoli AC; Fundacao Pio Xii Hospital Cancer De Barretos, Barretos, Brazil., Liu T; Zhongshan Hospital Fudan University, Shanghai, China., Tehfe M; Oncology Center - Centre Hospitalier de l'Universite de Montreal, Montreal, Canada., Elimova E; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Bruges R; Instituto Nacional de Cancerologia E.S.E., Bogotá, Colombia., Zander T; University of Cologne, Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düesseldorf; Gastrointestinal Cancer Group Cologne (GCGC), Cologne, Germany., de Azevedo S; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Kowalyszyn R; Instituto Multidisciplinario de Oncologia, Clinica Viedma S.A., Viedma, Argentina., Pazo-Cid R; Hospital Universitario Miguel Servet, Zaragoza, Spain., Schenker M; SF Nectarie Oncology Center, Craiova, Romania., Cleary JM; Dana Farber Cancer Institute, Boston, MA, USA., Yanez P; Universidad de La Frontera, James Lind Cancer Research Center, Temuco, Chile., Feeney K; St John of God Murdoch Hospital, Murdoch, Australia., Karamouzis MV; Laiko General Hospital of Athens, Athens, Greece., Poulart V; Bristol Myers Squibb, Princeton, NJ, USA., Lei M; Bristol Myers Squibb, Princeton, NJ, USA., Xiao H; Bristol Myers Squibb, Princeton, NJ, USA., Kondo K; Bristol Myers Squibb, Princeton, NJ, USA., Li M; Bristol Myers Squibb, Princeton, NJ, USA., Janjigian YY; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. janjigiy@mskcc.org.

المصدر: Nature [Nature] 2022 Mar; Vol. 603 (7903), pp. 942-948. Date of Electronic Publication: 2022 Mar 23.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Esophageal Neoplasms*/drug therapy , Stomach Neoplasms*/drug therapy, B7-H1 Antigen ; Esophagogastric Junction ; Follow-Up Studies ; Humans ; Ipilimumab/adverse effects ; Ipilimumab/therapeutic use ; Nivolumab/adverse effects ; Nivolumab/therapeutic use

SCR Disease Name: Adenocarcinoma Of Esophagus